MILLER AINE (SVP, DEV & HEAD OF IRE OFFICE) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 5/22/2026ACC: 0002012524-26-000004
Officer· SVP, DEV & HEAD OF IRE OFFICE
Since Feb 2026
-6.83K
Net shares
Net seller
$113.0K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
6.83K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−6.83K
Price / share
$16.55
Trade value
$112.99K
% of position
3.7%
5/20/2026
184.16K→177.33K
Total
Net shares
−6.83K
Net value
-$112.99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 5/20/2026 | F · Tax Withholding | −6.83K | $16.55 | $112.99K | 3.7% | 184.16K | 177.33K |
| Total | −6.83K | -$112.99K | ||||||
Derivative Transactions0
No derivative transactions reported